Skip to content
Menu

C4 Therapeutics, Inc. CCCC

Full chart Compare
Set alert

Price alert · CCCC

All alert types
2.48 USD +0.04 (+1.64%)

Regular-session close

2.37 -0.11 -4.42%

After hours · Nov 20, 4:22 PM ET

2.32 Day range 2.55
1.69 52-week range 5.17
YTD
+29.84%
1 year
+4.20%

Revenue & Expenses

Revenue Profit Costs
Other Operating Income$7.97MGross Profit$27.97MNet Loss$104.99MCost of Revenue$7.97MExpenses$140.94MSelling, General & Admin$36.20MResearch & Development$104.24MOther Expenses$384.00KIncome Tax$121.00KRevenue$35.95M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CCCC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
35.95M35.58M20.76M31.10M45.78M
35.95M35.58M20.76M31.10M45.78M
-115.22M-119.61M-139.03M-129.53M-82.13M
-104.99M-105.32M-132.49M-128.18M-83.89M
-1.27-1.52-2.67-2.62-1.82
CCCC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
78.05M58.94M130.03M33.03M79.40M
359.07M349.60M376.45M430.84M506.76M
102.49M133.62M130.34M141.61M117.16M
59.98M65.76M70.98M87.15M42.88M
256.59M215.99M246.11M289.23M389.61M
CCCC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-98.69M-65.16M-106.84M-105.94M-86.97M
-8.60M-51.27M158.35M58.42M-189.34M
126.40M45.34M45.49M1.15M171.40M
-607.00K-180.00K-1.71M-5.50M-1.28M
19.10M-71.09M97.00M-46.37M-104.90M